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The importance of telomere biology in human disease is in-
creasingly recognized and, in parallel, use of telomere
length (TL) measures is proliferating in epidemiological
and clinical studies. Such studies measure leukocyte TL
(LTL) using several methodological approaches. Shorter
LTL is associated with atherosclerosis1 and all-cause mor-
tality.2 Given the increasingly recognized role of TL in
human ageing and its related diseases, it is essential to
know more about the reliability and validity of TL meas-
urement methods, their comparability and which method
is optimal for a specific epidemiological/clinical setting.
In an effort to address this knowledge gap, Martin-Ruiz
et al. (MR)3 studied the reliability of TL measurement
techniques. They compared the popular qPCR method
with the labour-intensive Southern blots (SBs) and single
telomere length analysis (STELA). MR concluded that ‘nei-
ther technique nor laboratory had strong influence on re-
sult variation’, and that ‘Southern blotting and qPCR are
similar in their reproducibility’. Unfortunately, for the fol-
lowing reasons we believe that for epidemiological studies
neither conclusion is justified by the data.
Reliability of LTL
Most DNA samples (10/12) used by MR were obtained
from human placenta, cell cultures and cancer cells.
However, the inter-assay reliability of LTL is the pertinent
parameter for epidemiological studies. MR included only
two DNA samples from leukocytes and, because these were
added in the second round of the study, they could not be
used to measure inter-assay reliability of LTL. TL results for
human placenta, cultured and cancer cells cannot be auto-
matically generalized to LTL reliability, which is the pri-
mary concern of epidemiologists. Note also that MR used
pooled leukocyte samples of multiple donors, and effects of
pooling on assay reliability can therefore not be excluded. A
previous comparison of LTL reliability has been done for
the SB and the qPCR methods in a study4 cited by MR. The
study reported a clear difference in inter-assay coefficient of
variation (CV) between SB ¼ 1.74% and qPCR ¼ 6.54%,
using 50 leukocyte DNA samples from individual donors.
Moreover, Steenstrup et al.5 investigated whether LTL elon-
gation in longitudinal studies can be attributed to measure-
ment error vs a real biological phenomenon. They found
little evidence for LTL elongation over and above the effects
expected from measurement error. At the same time, the
available data indicated a substantially larger proportion of
individuals with an apparent LTL elongation in qPCR-
based studies when compared with SB-based studies. In our
view, the most parsimonious explanation for this finding is
the higher measurement error of the qPCR method.
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MR observed that rank correlations between measure-
ments obtained in different laboratories and with different
methods were high, reflecting similar rank orders of the
observations. Due to the inclusion of different cell types,
the range of TLs in this study (4.7-9.2 kb) is much higher,
however, than the age group-specific range (about 3 kb by
direct SBs within age groups) used in most epidemiological
studies of LTL. This will have inflated the rank correlation
beyond what is relevant for LTL in epidemiological studies
considerably, contributing to the erroneous conclusion
that the SB and qPCR methods yielded similar results.
Sample size and composition
MR used 12 samples. These were measured by two labora-
tories using SBs, one laboratory using STELA and seven
laboratories using qPCR. As both the number of samples
and the number of laboratories using techniques other than
qPCR were low, the statistical tests used by MR to infer no
difference in reliability between methods are underpowered
and consequently of limited value. We are thus left puzzled
by the authors’ claim of > 95% power to detect the differ-
ence previously reported between inter-assay CVs for LTL
using SBs and qPCR in 50 leukocyte DNA samples.4 MR
provide no details of their calculation in support of this
statement, nor on the exact difference between inter-assay
CVs for which they calculated their statistical power.
Furthermore, the authors combined the two SB and one
STELA laboratories for comparisons of inter-laboratory
CV across methods. We see little scientific justification for
this choice, which in effect leaves one with no information
specific to either the SB or STELA technique. For the two
leukocyte samples, the inter-laboratory CVs were 6.2%
and 6.5% for the SB/STELA laboratories vs 22.2% and
22.2% for the qPCR laboratories (samples K and L, Table
2, in erratum MR)6. These results, albeit from a tiny sam-
ple size, are consistent with higher measurement error of
the qPCR over SB/STELA based-methods. This is not spe-
cific for the leukocyte samples; overall the inter-laboratory
CVs were substantially higher when using qPCR
(P¼ 0.001 according to MR). Finally, for the crucial analy-
ses of the inter-assay and intra-assay CVs, the total number
of DNA samples was restricted to 5 and 3, respectively,
and none of these were from leukocytes.
CV as a measure of reliability
A characteristic of the CV is its dependence on the mean,
and hence the implicit assumption when using the CV is
heteroscedasticity, i.e. that the variance is proportional to
the mean. We examined whether this assumption holds in
the results presented by MR. Figure 1 suggests that it holds
for SB. There is a negligible correlation between mean and
CV, which is not surprising given the logarithmic nature of
molecular size ladders on gels.7 By contrast, Figure 1 sug-
gests that it does not hold for qPCR. There is a strong neg-
ative correlation between average TL and CV, which
implies that the error made in qPCR-based TL measure-
ments is not proportional to the mean, but instead is closer
to a constant (assay-specific) value. Such a finding under-
mines the CV as a reliability measure for qPCR-based TL
studies. Instead we recommend using the intra-class corre-
lation coefficient, which yields an informative estimate,
provided that the ‘test’ samples are similarly distributed as
the samples in the investigated population.
Figure 1 also illustrates the larger range of values
obtained with qPCR when compared with SB. MR suggest
that the larger ‘dynamic range’ obtained with qPCR com-
pensates for the lower precision of the method. However,
when CV values are calculated for SB laboratories alone
(i.e. ignoring the STELA results), the inter-laboratory CV
is in fact over 40% higher for the qPCR laboratories
(paired t-test, t¼ 2.39, df¼ 18, P< 0.025). Therefore, the
larger range in TL values obtained using qPCR compared
with SBs was more likely to be caused by a lower precision
of qPCR, rather than compensating for it.
DNA quality
MR reported that they assessed DNA quality (purity and
integrity) by ‘UV spectroscopy and agarose gel
Figure 1. Coefficient of variation (CV%) between laboratories for SB/
STELA vs qPCR plotted against telomere length. Telomere length was
standardized per laboratory, dividing the results for all samples by the
value obtained for sample G. The X-axis displays the average relative
telomere length per sample per technique. Data from Table 2, round 1,
in MR (SB/STELA R2¼ 0.06, qPCR R2¼ 0.54). Round 2 yielded similar
results, except that the non-significant trend for SB/STELA was positive
instead of negative.
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electrophoresis’, which is not typical of epidemiological
studies that use the qPCR-based method. This may be crit-
ical if qPCR-based results are influenced by DNA integrity,
which cannot be ruled out, as intact amplifiable target
sequences are essential for reliable and valid results.8
Therefore, it is important to demonstrate in impartial stud-
ies that DNA integrity does not affect the T/S ratio results.
Conclusions
We see little evidence in MR that the reliabilities of SB and
qPCR in measuring TL are equivalent. The number of labo-
ratories performing SBs and STELA in their study was very
small, as was the number of samples examined. Furthermore,
only two of the 12 samples were from human leukocytes, the
standard cell type used in epidemiological studies, and the
inter-assay reliability of LTL was not measured.
The qPCR does have the advantage over SB and other
methods in that it costs less and requires fewer resources,
but at the expense of measurement reliability. This implies
that to demonstrate the same effect statistically, a larger
sample size is needed when using qPCR in comparison
with using SB/STELA. It is informative therefore to exam-
ine the consequences of lower reliability (higher CVs) for
the actual sample sizes required. The following example
might serve to contextualize the impact of inter-assay CVs
on required sample sizes. On average, women’s LTL is lon-
ger by 0.15 kb than men’s LTL. As shown in Figure 2, to
detect this difference with 90% power, with an increase in
inter-assay CV from 2 to 20%, the required sample size
increases by approximately six-fold.
The paper by MR and this commentary highlight an
issue that is of great importance to the future of telomere
epidemiology. As proposed in the pages of this journal 5
years ago,9 large-scale epidemiological studies, based on
measurements of LTL using both SB and qPCR in labora-
tories experienced in these techniques, are urgently needed
to resolve matters related to ‘noise’ and to assess how the
two methods compare in capturing the associations of LTL
with a host of human traits. Without such comparison, we
fear that the claim by MR that SB and qPCR are equally
reliable methods to measure LTL may result in suboptimal
choices of methods, thereby wasting precious resources.
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Figure 2. Effect of inter-assay coefficient of variation (CV%) on sample
size required for a statistical power of 0.9. Shown on the left axis are the
multiples of the sample size needed compared with CV¼ 0% (i.e. perfect
reliability). The required number of multiples is independent of effect
size. Shown on the right axis is the N required for the specific case of
demonstrating a difference of 0.15 kb (approximate gender effect) with
power 0.9. Calculations are based on a two-sample t-test and power
analyses were carried out using G-Power, assuming an LTL
average6SD of 6.96 0.65 kb. Estimates depend on the sample size
used to calculate the CV due to the downward bias in SD estimates, and
this bias decreases rapidly with sample size over which each CV is cal-
culated. Upper line: CV based on sample standard deviation estimated
from duplicate measurements (maximum bias). Lower line: CV based
on population SD, i.e. unbiased.
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